What top creators are saying about Nattokinase(NATTO)
Enzyme derived from fermented soy used for cardiovascular health.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Nattokinase in the last 30 days yet.
Top creators covering Nattokinase (NATTO)
The 2 sources with the most insights about Nattokinase on Kazuha.
Latest insights about Nattokinase (NATTO)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, April 27, 2026
Clinical trials at doses of 10,000 units show potential to reverse arterial plaque.
Clinical trials suggest high doses can reverse arterial plaque, representing a significant preventative health opportunity.
Monday, April 27, 2026
Clinical trials at doses of 10,000 units show potential to reverse arterial plaque.
Clinical trials suggest high doses can reverse arterial plaque, representing a significant preventative health opportunity.
Discussed alongside Nattokinase (NATTO)
Other assets that creators frequently mention in the same content as Nattokinase.
Frequently asked
Which podcasters and creators cover Nattokinase (NATTO) the most?
The most active sources covering Nattokinase (NATTO) on Kazuha are @peterdiamandis, PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Nattokinase (NATTO) are on Kazuha?
Kazuha has indexed 2 AI-extracted insights about Nattokinase (NATTO) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Nattokinase (NATTO)?
Creators covering Nattokinase (NATTO) most frequently also discuss RESV, BERB, NMN, PRIVATE, METF. See the "Discussed alongside" section above for full asset pages.